Literature DB >> 27986969

Outbreaks of syphilis among men who have sex with men attending STI clinics between 2007 and 2015 in the Netherlands: a space-time clustering study.

F van Aar1, C den Daas1, M A B van der Sande1,2, L C Soetens1,3, H J C de Vries4,5,6, B H B van Benthem1.   

Abstract

OBJECTIVES: Infectious syphilis (syphilis) is diagnosed predominantly among men who have sex with men (MSM) in the Netherlands and is a strong indicator for sexual risk behaviour. Therefore, an increase in syphilis can be an early indicator of resurgence of other STIs, including HIV. National and worldwide outbreaks of syphilis, as well as potential changes in sexual networks were reason to explore syphilis trends and clusters in more depth.
METHODS: National STI/HIV surveillance data were used, containing epidemiological, behavioural and clinical data from STI clinics. We examined syphilis positivity rates stratified by HIV status and year. Additionally, we performed space-time cluster analysis on municipality level between 2007 and 2015, using SaTScan to evaluate whether or not there was a higher than expected syphilis incidence in a certain area and time period, using the maximum likelihood ratio test statistic.
RESULTS: Among HIV-positive MSM, the syphilis positivity rate decreased between 2007 (12.3%) and 2011 (4.5%), followed by an increasing trend (2015: 8.0%). Among HIV-negative MSM, the positivity rate decreased between 2007 (2.8%) and 2011 also (1.4%) and started to increase from 2013 onwards (2015: 1.8%). In addition, we identified three geospatial clusters. The first cluster consisted of MSM sex workers in the South of the Netherlands (July 2009-September 2010, n=10, p<0.001). The second cluster were mostly HIV-positive MSM (58.5%) (Amsterdam; July 2011-December 2015; n=1123, p<0.001), although the proportion of HIV-negative MSM increased over time. The third cluster was large in space (predominantly the city of Rotterdam; April-September 2015, n=72, p=0.014) and were mostly HIV-negative MSM (62.5%).
CONCLUSIONS: Using SaTScan analysis, we observed several not yet recognised outbreaks and a rapid resurgence of syphilis among known HIV-positive MSM first, but more recently, also among HIV-negative MSM. The three identified clusters revealed locations, periods and specific characteristics of the involved MSM that could be used when developing targeted interventions. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  GAY MEN; HIV; SYPHILIS

Mesh:

Year:  2016        PMID: 27986969     DOI: 10.1136/sextrans-2016-052754

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  An Update on the Global Epidemiology of Syphilis.

Authors:  Noah Kojima; Jeffrey D Klausner
Journal:  Curr Epidemiol Rep       Date:  2018-02-19

2.  The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe.

Authors:  G Spiteri; M Unemo; O Mårdh; A J Amato-Gauci
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

3.  Simple-to-use nomogram for predicting the risk of syphilis among MSM in Guangdong Province: results from a serial cross-sectional study.

Authors:  Peizhen Zhao; Ziying Yang; Baohui Li; Mingzhou Xiong; Ye Zhang; Jiyuan Zhou; Cheng Wang
Journal:  BMC Infect Dis       Date:  2021-11-29       Impact factor: 3.090

4.  Spatio-temporal variation on syphilis from 2005 to 2018 in Zhejiang Province, China.

Authors:  Xiaoxia Zhu; Zhixin Zhu; Lanfang Gu; Yancen Zhan; Hua Gu; Qiang Yao; Xiuyang Li
Journal:  Front Public Health       Date:  2022-08-25

5.  Distribution of reported syphilis cases in South China: spatiotemporal analysis.

Authors:  Ngai Sze Wong; Lei Chen; Joseph D Tucker; Peizhen Zhao; Beng Tin Goh; Chin Man Poon; Ligang Yang; Bin Yang; Heping Zheng; Shujie Huang
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.